Kimmel Cancer Center researchers prove that high - dose
cyclophosphamide therapy, administered alone (without bone marrow transplantation), is an effective therapy for many aplastic anemia patients.
Not exact matches
Luznik says that the researchers» next step will be to test the short course
therapy in a phase III randomized clinical trial that would directly compare results in patients who receive the
cyclophosphamide treatment with those who receive either a separate, experimental approach to prevent GVHD or the more traditional six - month immunosuppressive
therapy.
Patients given the 200 mg dose saw the most promising results and the study was able to conclude that, «phytochemicals from the avocado fruit can be utilized in making active chemoprotective ingredients (s) for lowering the side effect of chemotherapy like
cyclophosphamide in cancer
therapy».
Ten of the 15 vaccinated dogs (66.7 %) in Group 2 that relapsed were treated with
cyclophosphamide, vincristine, and prednisone (COP) as salvage
therapy and four of these dogs (40 %) achieved durable second clinical remission (> 22 months) and did not relapse.